Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities-Reference-Cited by-同舟云学术

Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities

Published:2020-08-19 Issue:4 Volume:72 Page:1253-1266
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Goeppert Benjamin¹,Folseraas Trine²³⁴⁵⁶,Roessler Stephanie¹,Kloor Matthias⁷,Volckmar Anna‐Lena¹,Endris Volker¹,Buchhalter Ivo¹⁸,Stenzinger Albrecht¹,Grzyb Krzysztof⁹,Grimsrud Marit M.²³⁴,Gornicka Barbara¹⁰,Seth Erik¹¹,Reynolds Gary M.¹²,Franke Andre¹³,Gotthardt Daniel N.¹⁴,Mehrabi Arianeb¹⁵,Cheung Angela¹⁶,Verheij Joanne¹⁷,Arola Johanna¹⁸,Mäkisalo Heikki¹⁹,Eide Tor J.⁹,Weidemann Sören²⁰,Cheville John C.²¹,Mazza Giuseppe²²,Hirschfield Gideon M.¹²²³,Ponsioen Cyriel Y.²⁴,Bergquist Annika¹¹,Milkiewicz Piotr²⁵²⁶,Lazaridis Konstantinos N.¹⁶,Schramm Christoph²⁷²⁸,Manns Michael P.²⁹,Färkkilä Martti³⁰,Vogel Arndt²⁹,Boberg Kirsten M.²³⁴⁵⁶,Schirmacher Peter¹,Karlsen Tom H.²³⁴⁵⁶,

Affiliation:

1. Department of General Pathology, Institute of Pathology University Hospital Heidelberg Heidelberg Germany

2. Norwegian PSC Research Center Department of Transplantation Medicine Division of Surgery, Inflammatory Medicine and Transplantation Oslo University Hospital Rikshospitalet Oslo Norway

3. Institute of Clinical Medicine Faculty of Medicine University of Oslo Oslo Norway

4. Research Institute of Internal Medicine Division of Surgery, Inflammatory Medicine and Transplantation Oslo University Hospital Rikshospitalet Oslo Norway

5. K.G. Jebsen Inflammation Research Center Institute of Clinical Medicine Faculty of Medicine University of Oslo Oslo Norway

6. Section for Gastroenterology Department of Transplantation Medicine Division of Surgery, Inflammatory Medicine and Transplantation Oslo University Hospital Rikshospitalet Oslo Norway

7. Department of Applied Tumor Biology Institute of Pathology University of Heidelberg Heidelberg Germany

8. Institute of Pathology, Omics IT and Data Management Core Facility, German Cancer Research Center (DKFZ) Heidelberg Germany

9. Department of Pathology Oslo University Hospital Oslo Norway

10. Department of Pathology Medical University of Warsaw Warsaw Poland

11. Department of Gastroenterology and Hepatology Karolinska Institutet Karolinska University Hospital Stockholm Sweden

12. Center for Liver Research NIHR Birmingham Liver Biomedical Research Unit University of Birmingham Birmingham United Kingdom

13. Institute of Clinical Molecular Biology Christian‐Albrechts University Kiel Germany

14. Department of Internal Medicine IV University Hospital Heidelberg Heidelberg Germany

15. Department of General, Visceral and Transplantation Surgery University of Heidelberg Heidelberg Germany

16. Division of Gastroenterology and Hepatology Mayo Clinic Rochester MN

17. Department of Pathology Academic Medical Center Amsterdam the Netherlands

18. Department of Pathology Haartman Institute and Huslab Helsinki University Hospital Helsinki Finland

19. Department of Transplantation and Liver Surgery Helsinki University Hospital Helsinki Finland

20. Institute of Pathology University Medical Center Hamburg‐Eppendorf Hamburg Germany

21. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN

22. Division of Medicine Institute for Liver and Digestive Health Royal Free Hospital University College London London United Kingdom

23. University Hospital Birmingham NHS Foundation Trust Birmingham United Kingdom

24. Department of Gastroenterology and Hepatology Academic Medical Center Amsterdam the Netherlands

25. Liver and Internal Medicine Unit Medical University of Warsaw Warsaw Poland

26. Translational Medicine Group Pomeranian Medical University Szczecin Poland

27. Department of Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany

28. Martin Zeitz Center for Rare Diseases University Medical Center Hamburg‐Eppendorf Hamburg Germany

29. Department of Gastroenterology, Hepatology and Endocrinology Hannover Medical School Hannover Germany

30. Department of Gastroenterology & Hepatology Helsinki University Hospital Helsinki Finland

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31110

Reference35 articles.

1. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

2. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

3. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

4. Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis

5. Aspirin use and the risk of cholangiocarcinoma

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biliary stem cells in health and cholangiopathies and cholangiocarcinoma;Current Opinion in Gastroenterology;2024-02-08

2. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs;Biomedicine & Pharmacotherapy;2023-12

3. Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies;Gut;2023-11-24

4. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies;Cancers;2023-10-11

5. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis;Experimental & Molecular Medicine;2023-07-18